Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
82.81
-2.34 (-2.75%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
3 Surprisingly Underrated Stocks to Buy Right Now
July 28, 2025
These big pharma stocks arguably aren't receiving the respect they deserve.
Via
The Motley Fool
Topics
Intellectual Property
What To Expect From Merck’s (MRK) Q2 Earnings
July 27, 2025
Global pharmaceutical company Merck (NYSE:MRK) will be reporting earnings this Tuesday before market open. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills
July 26, 2025
Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.
Via
Benzinga
Topics
Artificial Intelligence
ETFs
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
July 25, 2025
AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma struggles.
Via
Benzinga
P/E Ratio Insights for Merck & Co
July 24, 2025
Via
Benzinga
Merck Commits To Veeva’s Vault CRM, Draws Wall Street Cheer: Retail’s Not Enthusiastic
July 21, 2025
Via
Stocktwits
Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided
July 21, 2025
Via
Stocktwits
Merck & Co. Inc. (NYSE:MRK): A Strong Value Investment with Undervalued Potential
July 25, 2025
Merck & Co. (MRK) is a top value stock with strong fundamentals—undervalued P/E, high profitability, stable finances, and steady growth, making it a smart pick for value investors.
Via
Chartmill
Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results
July 23, 2025
The results represent a best-case scenario for the company in treating inflammatory bowel disease, according to one analyst.
Via
Investor's Business Daily
Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock
July 22, 2025
The company had lined up a priority review in the hopes of winning an accelerated approval for its melanoma treatment.
Via
Investor's Business Daily
Merck Announces Fourth-Quarter 2025 Dividend
July 22, 2025
From
Merck & Co., Inc.
Via
Business Wire
Merck & Co Unusual Options Activity For July 15
July 15, 2025
Via
Benzinga
Adagene Receives FDA Guidance On Future Clinical Development Of Experimental Cancer Drug: Retail Turns Optimistic
July 15, 2025
Via
Stocktwits
MERCK & CO. INC. (NYSE:MRK) – A Quality Stock with Strong Fundamentals
July 22, 2025
MERCK & CO. INC. (NYSE:MRK) is a high-quality stock with strong profitability, efficient capital use, and a reliable dividend, making it a solid pick for long-term investors.
Via
Chartmill
Does This Move Make Merck Stock a Buy?
July 20, 2025
Via
The Motley Fool
Topics
Intellectual Property
Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?
July 20, 2025
Via
The Motley Fool
Topics
Economy
Intellectual Property
Want Decades of Passive Income? Buy This ETF and Hold It Forever
July 19, 2025
Via
The Motley Fool
Topics
ETFs
Regulatory Compliance
Stocks
MERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 19, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Got $200? 2 Dividend Stocks to Buy and Hold Forever
July 19, 2025
Via
The Motley Fool
Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business
July 17, 2025
Via
The Motley Fool
Topics
Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
July 16, 2025
Via
Benzinga
1 Dow Jones Stock to Target This Week and 2 to Avoid
July 16, 2025
While the Dow Jones (^DJI) represents industry leaders, not every stock in the index is a safe bet. Some are facing headwinds like declining demand, rising costs, or disruptive new competitors.
Via
StockStory
Topics
Stocks
GSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults
July 15, 2025
FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the first half of 2026.
Via
Benzinga
This House of Representative Just Bought Up To $30K In 3M Stock
July 15, 2025
Via
Benzinga
Is Bristol-Myers Squibb Still An Undervalued Biopharma Play?
July 14, 2025
BofA cuts Bristol Myers' 2025 EPS and sales estimates slightly and flags medium-term pressure from generics, while maintaining a Neutral rating.
Via
Benzinga
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
July 14, 2025
From
Merck & Co., Inc.
Via
Business Wire
AstraZeneca's Drug Shows Promise For Resistant Hypertension In Phase 3 Trial
July 14, 2025
AstraZeneca's Phase 3 trial showed baxdrostat lowered systolic blood pressure in treatment-resistant hypertension with a favorable safety profile.
Via
Benzinga
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
July 11, 2025
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.
Via
Benzinga
Topics
Government
World Trade
MERCK & CO. INC. (NYSE:MRK) – A Strong Dividend Stock with Solid Fundamentals
July 11, 2025
MERCK & CO. (NYSE:MRK) offers a strong 4% dividend yield, consistent growth, and solid profitability, making it a top pick for income investors. The stock is also attractively valued.
Via
Chartmill
2 Top Stocks Down 16% and 17% This Year to Buy and Hold
July 11, 2025
Via
The Motley Fool
Topics
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.